The result of the state Certificate of Need competition could have big repercussions for Western North Carolina’s health care ...
A formulation of MSD's cancer drug Keytruda that can be given by subcutaneous injection rather than intravenous infusion has cleared a phase 3 trial, setting up approvals later this year. The ...
For the best experience in completing this form use a non-mobile device.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback